PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 19, 2026BMC Infectious Diseases2 citationsOpen Access

Epidemiology of tick-borne diseases diagnosed in patients in north-eastern Italy, 2015–2022

View Full Paper
GFGiulio FlaminioUniversity of PaduaEGElena GhiorziUniversity of PaduaMBM. BattistelMartin University

Key Points

  • This study aims to evaluate the prevalence and diagnostic trends of tick-borne diseases in northeastern Italy from 2015 to 2022.
  • Analyzed over 49,000 human samples from four hospitals
  • Conducted serological screening for Lyme borreliosis, rickettsiosis, anaplasmosis, babesiosis, and tick-borne encephalitis
  • Monitored trends in disease positivity rates across different years and age groups
  • Over 52,000 serological tests conducted, mainly for Lyme borreliosis (78.4%) and tick-borne encephalitis (16.7%)
  • Positivity rates for Lyme borreliosis were 14.8% and 21% for tick-borne encephalitis, showing an increasing trend over the study period
  • Rickettsiosis showed a positivity rate of 11.5%, stable across genders and age groups
  • Anaplasmosis diagnostics had a maximum positivity rate of ~9%, while babesiosis testing suggested up to 50% positivity in recent years

Abstract

Background Ixodes ricinus is the most abundant tick species in Europe and a primary vector for multiple pathogens affecting human and animal health. Over the past 70 years in Europe, including Italy, the geographical distribution of I. ricinus has expanded, increasing the opportunities for tick-human interactions. This observational retrospective study evaluates tick-borne disease (TBD) diagnostic activities conducted from 2015 to 2022 in northeastern Italian hospitals, focusing on areas with significant I. ricinus presence. Methods Data from over 49,000 human samples that underwent serological screening for Lyme borreliosis (LB), rickettsiosis, anaplasmosis, babesiosis, and tick-borne encephalitis (TBE) were extracted from the information systems of the 4 participating hospitals. Results Over 52,000 individual serological tests on this population with suspected TBD were performed, primarily for LB (78.4%) and TBE (16.7%), with positivity rates of 14.8% and 21%, respectively, showing significant increasing trend between 2015 and 2022. Male patients predominated (51% for LB and 61% for TBE), especially for IgG positivity, with the 60–69 (LB) and 40–49 (TBE) age groups most affected. Rickettsiosis testing revealed 11.5% positivity with a stable trend, affecting both genders equally, predominately in the 30–39 age group. Anaplasmosis diagnostics (248 tests) showed a maximum positivity rate of ~ 9%, while limited babesiosis testing (64 tests) indicated up to 50% positivity in recent years. Conclusions The findings underscore the need for enhanced diagnostic tests, vigilant surveillance, and ongoing public education on TBD risks as crucial strategies to mitigate infection risk and reduce the public health impact of TBDs in the northeastern of Italy. Clinical trial number Not applicable.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Flaminio et al. (2026) studied this question.

synapsesocial.com/papers/69bb91c7496e729e6297f35bhttps://doi.org/10.1186/s12879-026-13078-z
Ask AI
Helpful
Bookmark
Share
View Full Paper